Autopsy report · NCT00634166

Effects of Therapy With Sulfamylon® 5% Topical Solution Compared to a Historical Control Group

“FDA request as study could not serve as the confirmatory trial.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 5 months after it had already started.
• Ran for about 6 years 7 months before it stopped.
• 220 participants enrolled.
• Results were posted on the registry 5 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 4

Sponsor

Mylan Inc.

Sponsor type

Industry

Conditions

Burns

Interventions

Sulfamylon® For 5 % Topical Solution; Topical Antimicrobial/Antifungal Medications

Participants

220

Sites

9

Countries

United States

Trials that died the same way

• Novel Triple-dose Tuberculosis Retreatment Regimens: How to Overcome Resistance Without Creating More
  “Feasibility of the clinical trial could not be confirmed at the different sites.” (79% match in meaning)
• Iontophoresis in Psoriasis
  “FDA did not provide approval of the use of the drug for the study” (78% match in meaning)
• Exploring the Impact of Two-week Kava on the Metabolism of Nicotine and NNK
  “Terms could not be met with the FDA.” (77% match in meaning)
• Effects of a Supplement Derived From Palm Oil on Cholesterol Levels and Chinese Red Yeast Rice in the Blood
  “We were unable to procure the supplement for this study.” (72% match in meaning)
• DASH - Decision Making in Adolescent Sexual Health
  “This research was not conducted at UNM \& not Applicable Clinical Trial.” (71% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.